Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib
Samuel J. Taylor, Johanna M. Duyvestyn, Samantha A. Dagger, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 402
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer
Dnyaneshwar Kalyane, Nidhi Raval, Rahul Maheshwari, et al.
Materials Science and Engineering C (2019) Vol. 98, pp. 1252-1276
Closed Access | Times Cited: 715
Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study
Lowell L. Hart, Renata Ferrarotto, Zoran Andrić, et al.
Advances in Therapy (2020) Vol. 38, Iss. 1, pp. 350-365
Open Access | Times Cited: 90
Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors
Robert S. Epstein, Matti Aapro, Upal Kunal Basu Roy, et al.
Advances in Therapy (2020) Vol. 37, Iss. 8, pp. 3606-3618
Open Access | Times Cited: 73
Oxygen-carrying microfluidic microcapsules for enhancing chemo-sonodynamic therapy on patient-derived tumor organoid models
Danqing Huang, Cheng Zhao, Baojie Wen, et al.
Chemical Engineering Journal (2022) Vol. 435, pp. 134871-134871
Closed Access | Times Cited: 52
Chemotherapy-induced anemia: etiology, pathophysiology, and implications for contemporary practice
Emily Bryer, David H. Henry
International Journal of Clinical Transfusion Medicine (2018) Vol. Volume 6, pp. 21-31
Open Access | Times Cited: 62
Ultrasound‐Responsive Microfluidic Microbubbles for Combination Tumor Treatment
Danqing Huang, Xiaoxuan Zhang, Cheng Zhao, et al.
Advanced Therapeutics (2021) Vol. 4, Iss. 7
Closed Access | Times Cited: 35
Discovery of Potent and Selective CDK4/6 Inhibitors for the Treatment of Chemotherapy-Induced Myelosuppression
Wei Shi, Rong Wang, Jianqiang Qian, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in FLT3-ITD Acute Myeloid Leukemia
Pierre‐Yves Dumas, Arnaud Villacreces, Amélie V. Guitart, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 21, pp. 6012-6025
Open Access | Times Cited: 25
Cancer Patients’ Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life
Robert S. Epstein, Upal Kunal Basu Roy, Matti Aapro, et al.
Patient Preference and Adherence (2021) Vol. Volume 15, pp. 453-465
Open Access | Times Cited: 24
Drug Repurposing for the Treatment of Acute Myeloid Leukemia
Vibeke Andresen, Bjørn Tore Gjertsen
Frontiers in Medicine (2017) Vol. 4
Open Access | Times Cited: 33
STS1 and STS2 Phosphatase Inhibitor Baicalein Enhances the Expansion of Hematopoietic and Progenitor Stem Cells and Alleviates 5-Fluorouracil-Induced Myelosuppression
Na Li, Yanhong Wang, Anqing Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2987-2987
Open Access | Times Cited: 8
Development of a Machine Learning-Based Prediction Model for Chemotherapy-Induced Myelosuppression in Children with Wilms’ Tumor
Mujie Li, Quan Wang, Peng Lu, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1078-1078
Open Access | Times Cited: 8
Targeting Immunophenotypic Markers on Leukemic Stem Cells: How Lessons from Current Approaches and Advances in the Leukemia Stem Cell (LSC) Model Can Inform Better Strategies for Treating Acute Myeloid Leukemia (AML)
Kelly Mitchell, Ulrich Steidl
Cold Spring Harbor Perspectives in Medicine (2019) Vol. 10, Iss. 1, pp. a036251-a036251
Open Access | Times Cited: 24
Exposure–Toxicity Association of Cyclophosphamide and Its Metabolites in Infants and Young Children with Primary Brain Tumors: Implications for Dosing
Olivia Campagne, Bo Zhong, Sreenath Nair, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 7, pp. 1563-1573
Open Access | Times Cited: 22
Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer
Chao Li, Lowell L. Hart, Taofeek K. Owonikoko, et al.
Cancer Chemotherapy and Pharmacology (2021) Vol. 87, Iss. 5, pp. 689-700
Open Access | Times Cited: 16
TPGS-Modified Long-Circulating Liposomes Loading Ziyuglycoside I for Enhanced Therapy of Myelosuppression
Tingting Song, Hong Wang, Yue Liu, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 6281-6295
Open Access | Times Cited: 15
Jujube Powder Enhances Cyclophosphamide Efficiency against Murine Colon Cancer by Enriching CD8+ T Cells While Inhibiting Eosinophilia
Huiren Zhuang, Nan Jing, Luoyang Wang, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2700-2700
Open Access | Times Cited: 14
Has Drug Repurposing Fulfilled Its Promise in Acute Myeloid Leukaemia?
Debora Valli, Alicja Gruszka, Myriam Alcalay
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 1892-1892
Open Access | Times Cited: 13
The construction of a lymphoma cell-based, DC-targeted vaccine, and its application in lymphoma prevention and cure
Tianlin Zhou, Jinrong Peng, Ying Hao, et al.
Bioactive Materials (2020) Vol. 6, Iss. 3, pp. 697-711
Open Access | Times Cited: 13
Chemotherapy-Induced Anemia in Adults Incidence and Treatment
S Nasim Ali, Ahmed Farhan Shallal, İbrahim Nazem Qader, et al.
Deleted Journal (2024) Vol. 2, Iss. 2, pp. 34-49
Open Access | Times Cited: 1
Co-delivery of protopanaxatriol/icariin into niche cells restores bone marrow niches to rejuvenate HSCs for chemotherapy-induced myelosuppression
Mengdi Xiao, Shiyi Hong, Peng Pei, et al.
Phytomedicine (2024) Vol. 134, pp. 155978-155978
Closed Access | Times Cited: 1
PAMAM-Based Polymeric Immunogenic Cell Death Inducer To Potentiate Cancer Immunotherapy
Hua Huang, Qi‐Song Tong, Yang Chen, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 42, pp. 29189-29198
Closed Access | Times Cited: 1
P-glycoprotein (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) limit brain accumulation of the FLT3 inhibitor quizartinib in mice
Jing Wang, Changpei Gan, Irene A. Retmana, et al.
International Journal of Pharmaceutics (2018) Vol. 556, pp. 172-180
Open Access | Times Cited: 12
Gata2-L359V impairs primitive and definitive hematopoiesis and blocks cell differentiation in murine chronic myelogenous leukemia model
Yakai Fu, Yun Tan, Bo Wu, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 10
Effect of Primary and Secondary Beads of Carbon Enterosorbent on Haematological Parameters and Oxidative Stress Development Caused by Melphalan in Rats
О. О. Шевчук, E. A. Snezhkova, Veronika Sarnatskaya, et al.
Medicina (2019) Vol. 55, Iss. 9, pp. 557-557
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top